Targeting HER3 could cripple metastatic cancers that have spread to the brain. (Bethesda, MD, June 5, 2017) Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported by the National Foundation for Cancer Research, has discovered a novel mechanism behind…...
Non-Invasive Liquid Biopsy Uncovers Key Information to Treat Cancer
A liquid biopsy can provide valuable insight into how to best fight cancer. This noninvasive diagnostic is particularly helpful for patients who cannot undergo a surgical biopsy or whose tumor sample has been exhausted. In the not-too-distant future, liquid biopsies may be used to guide cancer treatment decisions and even…...
Highlights of ASCO 2017
Founded in 1964, the American Society of Clinical Oncology (ASCO®) is the world’s leading professional organization for physicians and oncology professionals caring for people with cancer. Each year, tens of thousands of oncology professionals, cancer researchers and patient advocates gather at The ASCO Annual Meeting to discuss the latest in…...
2017 Szent-Györgyi Prize for Progress in Cancer Research Awarded to Michael N. Hall
More than 170 guests enjoyed a fabulous Monday evening at the National Press Club recognizing Michael N. Hall, Ph.D., Professor of Biochemistry at the Biozentrum of the University of Basel in Switzerland, as the 2017 recipient of the Szent-Györgyi Prize for Progress in Cancer Research presented by the National Foundation…...
Improving the Delivery and Efficacy of Anti-Cancer Therapeutics
In honor of National Medical Laboratory Professional Week, we’d like to highlight a few of the many accomplishments of NFCR-funded scientist, Dr. Rakesh Jain. About Dr. Rakesh Jain Rakesh K. Jain, Ph.D., Andrew Werk Cook professor of tumor biology (radiation oncology) at Harvard Medical School and director of the Edwin…...
Strategic Media Partner
